HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: EJE-08-0735v1 160/3/375    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Sondergaard, E Articles by Nielsen, S Search for Related Content PubMed PubMed Citation Articles by Sondergaard, E Articles by Nielsen, S

Visceral fat mass is a strong predictor of circulating ghrelin levels in premenopausal women

Medical Department M (Endocrinology & Diabetes), Aarhus University Hospital, DK-8000 Aarhus C, Denmark

(Correspondence should be addressed to E Sondergaard; Email: esbens{at}dadlnet.dk)

Objective: A well known inverse relationship exists between obesity and circulating ghrelin concentrations. However, obesity is a heterogeneous disease entity and upper-body obesity (UBO) is associated with more profound metabolic disturbances than lower-body obesity (LBO). We therefore aimed to investigate the impact of body composition on circulating ghrelin levels in women spanning a wide range of body composition phenotypes.

Subjects and methods: Ten (UBO; waist-to-hip ratio (WHR) >0.85, body mass index (BMI) >28 kg/m²), ten LBO (WHR <0.80, BMI >28 kg/m²) and ten lean women (BMI<25 kg/m²) were studied. Total ghrelin levels were measured under basal and hyperinsulinemic (0.6 mU/kg per min) conditions. Body fat distribution was determined by dual X-ray absorptiometry in combination with computed tomography at the L2-L3 level.

Results: As expected, an inverse correlation existed between basal ghrelin concentration and BMI (r=–0.40, P=0.03) and total fat mass (r=–0.39, P=0.04). Visceral fat mass was a strong predictor (r=–0.56, P=0.003) of circulating ghrelin levels, even when adjusted for BMI (P=0.02) or body composition group (P=0.04). The suppressive effect of insulin on ghrelin concentration was significantly diminished in the UBO compared with the lean controls (P=0.012) and a highly significant inverse correlation existed with visceral fat mass (r=–0.52, P=0.004).

Conclusions: Visceral fat mass is a strong predictor of basal ghrelin concentrations and also attenuates the suppressive effect of insulin on ghrelin concentrations. These data provide further evidence that the UBO phenotype is associated with more profound metabolic abnormalities than obesity per se.